Has Charissa Duffy, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $31,177 in general payments to Charissa Duffy, APRN across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charissa Duffy, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charissa Duffy, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charissa Duffy, APRN

Psychiatric/Mental Health · Medina, OHNPI 1689160442

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,944 of the $31,177 with a category attached, or 67.2%. Otsuka America Pharmaceutical, Inc. accounts for 85.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $27,229, more than ten times the $442 reported in 2021. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,177in general payments, 2019–2025

Across 164 payments — averaging $190.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$27K
Neurocrine Biosciences, Inc.$2K
Acadia Pharmaceuticals Inc$1K
AbbVie$195
Avanir Pharmaceuticals, Inc.$180
Alkermes, Inc.$131
plus $536 from 8 others

What the payments were for

Speaking & faculty fees$20,94467%
Travel & lodging$4,55815%
Food & beverage$5,66618%
Education$90%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	66	$26,790
Neurocrine Biosciences, Inc.	46	$1,997
Acadia Pharmaceuticals Inc	22	$1,349
AbbVie	7	$195
Avanir Pharmaceuticals, Inc.	2	$180
Alkermes, Inc.	2	$131
Teva Pharmaceuticals USA, Inc.	5	$131
Edwards Lifesciences	1	$117
Johnson & Johnson	4	$83
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$79
Sun Pharmaceutical Industries Inc.	1	$50
Lundbeck LLC	2	$33
Eisai Inc.	1	$25
Idorsia Pharmaceuticals US Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,177 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Medicare billing

Part B allowed, 2024

$30,538

Medicare patients

324

Services billed

463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Paliperidone ErPaliperidone	12	$3,019
Sertraline Hcl	122	$1,994
Fluvoxamine Maleate	38	$1,787
Mirtazapine	19	$1,124
Venlafaxine Hcl ErVenlafaxine Hcl	32	$718
Divalproex Sodium	26	$561
Risperidone	21	$469
Duloxetine Hcl	14	$384
Memantine Hcl	13	$330
Fluoxetine Hcl	23	$271
Quetiapine Fumarate	18	$213
Escitalopram Oxalate	16	$197
Olanzapine	19	$144
Buspirone Hcl	15	$134
Losartan Potassium	12	$127

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Medina

Tana WhittMedina$47K
Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →